Drug Profile
Human albumin - Intas Pharmaceuticals
Alternative Names: Albucel 20%Latest Information Update: 15 Oct 2021
Price :
$50
*
At a glance
- Originator Intas Pharmaceuticals
- Class Plasma expanders
- Mechanism of Action Protein replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Unspecified
Most Recent Events
- 31 Dec 2006 Launched for Undefined indication in France (unspecified route)